<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:media="http://search.yahoo.com/mrss/">
    <channel>
        <title><![CDATA[Sweden Herald - Stephen Gough]]></title>
        <description><![CDATA[The latest Sweden Herald stories about Stephen Gough, in English.]]></description>
        <link>https://swedenherald.com/people/stephen-gough</link>
        <generator>RSS for Node and Next.js</generator>
        <lastBuildDate>Sun, 22 Nov 2026 18:20:46 GMT</lastBuildDate>
        <atom:link href="https://swedenherald.com/rss/people/stephen-gough.xml" rel="self" type="application/rss+xml"/>
        <copyright><![CDATA[Sweden Herald]]></copyright>
        <language><![CDATA[en-US]]></language>
        <ttl>60</ttl>
        <item>
            <title><![CDATA[Ozempic can be given to more patients in the USA]]></title>
            <description><![CDATA[The Danish pharmaceutical company Novo Nordisk's diabetes medicine Ozempic has been approved for treating patients with chronic kidney disease, writes CNBC.]]></description>
            <link>https://swedenherald.com/article/ozempic-can-be-given-to-more-patients-in-the-usa</link>
            <guid isPermaLink="true">https://swedenherald.com/article/ozempic-can-be-given-to-more-patients-in-the-usa</guid>
            <category><![CDATA[Business News]]></category>
            <dc:creator><![CDATA[Sweden Herald]]></dc:creator>
            <pubDate>Tue, 28 Jan 2025 20:02:12 GMT</pubDate>
            <enclosure url="https://static.swedenherald.com/b5e2d68a-1def-4ded-bbce-489ca8bd1fb4/b5e2d68a-1def-4ded-bbce-489ca8bd1fb4.jpg" length="0" type="image/jpeg"/>
            <media:content url="https://static.swedenherald.com/b5e2d68a-1def-4ded-bbce-489ca8bd1fb4/b5e2d68a-1def-4ded-bbce-489ca8bd1fb4.jpg" medium="image" type="image/jpeg" width="1600" height="1067"/>
        </item>
    </channel>
</rss>